Related Experiment Videos
Isolation of restriction-reduced mutants from Streptomyces
S Kakinuma1, H Ikeda, H Tanaka
1School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.
Agricultural and Biological Chemistry
|October 1, 1990
Summary
Researchers developed restriction-reduced mutants in Streptomyces strains to improve antibiotic production. These modified strains show enhanced plasmid transformation efficiency, aiding genetic manipulation for nanaomycin and kalafungin biosynthesis.
Area of Science:
- Microbiology
- Molecular Biology
- Biotechnology
Background:
- Streptomyces species produce valuable antibiotics like nanaomycin and kalafungin.
- Efficient genetic manipulation is crucial for optimizing the production of these secondary metabolites.
- Restriction systems in bacteria can impede foreign DNA transformation, limiting genetic engineering efforts.
Purpose of the Study:
- To isolate and characterize restriction-reduced mutants of Streptomyces rosa and Streptomyces tanashiensis.
- To enhance the efficiency of plasmid transformation in these antibiotic-producing strains.
- To facilitate genetic studies and potential strain improvement for antibiotic biosynthesis.
Main Methods:
- Isolation of mutants from Streptomyces rosa subsp. notoensis and Streptomyces tanashiensis.
- Selection based on susceptibility to actinophage and ability to be transformed with multi-copy plasmids.
- Transformation with single-copy plasmids, with optimization including heat treatment of protoplasts.
Main Results:
- Restriction-reduced mutants of S. rosa and S. tanashiensis were successfully isolated.
- These mutants exhibited improved transformation efficiency with single-copy plasmids.
- Heat treatment of S. tanashiensis protoplasts significantly enhanced transformation rates.
Conclusions:
- The isolated mutants likely possess deficiencies in their native restriction systems.
- These restriction-reduced strains are valuable tools for genetic manipulation in Streptomyces.
- Enhanced transformation efficiency facilitates further research into nanaomycin and kalafungin production pathways.